NRXP
NRX Pharmaceuticals, Inc.
Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company
Total Trades
16
Buys
10
Sells
6
Largest Trade
$1M+
Insiders
7
Institutional Funds
21
Inst. Value
$1M+
Activist Filings
6
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Gorovitz Aaron | Director | BUY | $1K–$15K | 35K | $0.32 | Sep 11, 2023 |
| Hurvitz Chaim | Director | BUY | $15K–$50K | 70K | $0.29 | Sep 11, 2023 |
| Javitt Jonathan C | Chief Scientist | BUY | $15K–$50K | 100K | $0.33 | Aug 24, 2023 |
| Javitt Jonathan C | Chief Scientist | BUY | $50K–$100K | 200K | $0.32 | Aug 23, 2023 |
| Willard Stephen H | CHIEF EXECUTIVE OF… | BUY | $50K–$100K | 50K | $1.17 | Dec 19, 2022 |
| VAN VOORHEES SETH | CHIEF FINANCIAL OF… | BUY | $15K–$50K | 30K | $1.10 | Dec 19, 2022 |
| Javitt Jonathan C | Director | SELL | $100K–$500K | 400K | $1.00 | Dec 9, 2022 |
| Javitt Daniel C. | 10% Owner | SELL | $15K–$50K | 22K | $1.50 | Dec 2, 2022 |
| Flynn Patrick John | Director | BUY | $1K–$15K | 12K | $1.25 | Nov 29, 2022 |
| VAN VOORHEES SETH | CHIEF FINANCIAL OF… | BUY | $15K–$50K | 16K | $1.11 | Nov 28, 2022 |
| Hurvitz Chaim | Director | BUY | $500K+ | 500K | $1.03 | Nov 21, 2022 |
| Javitt Daniel C. | 10% Owner | SELL | $100K–$500K | 167K | $1.03 | Nov 19, 2022 |
| Javitt Daniel C. | 10% Owner | SELL | $15K–$50K | 49K | $1.01 | Nov 16, 2022 |
| Javitt Daniel C. | 10% Owner | SELL | $500K+ | 784K | $1.01 | Aug 2, 2022 |
| Javitt Daniel C. | 10% Owner | SELL | $100K–$500K | 446K | $0.68 | Jun 8, 2022 |
| Javitt Jonathan C | Chief Scientist | BUY | $1M+ | 100K | $58.00 | Jun 2, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 21 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| COMMONWEALTH EQUITY SERVICES, LLC | 367K | $500K+ | SH |
| AdvisorShares Investments LLC | 328K | $500K+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 186K | $500K+ | SH |
| Bleakley Financial Group, LLC | 117K | $100K–$500K | SH |
| VANGUARD GROUP INC | 103K | $100K–$500K | SH |
| STATE STREET CORP | 87K | $100K–$500K | SH |
| Global Retirement Partners, LLC | 39K | $100K–$500K | SH |
| One Wealth Management Investment & Advisory Services, LLC | 38K | $100K–$500K | SH |
| JANE STREET GROUP, LLC | 31K | $50K–$100K | SH (Call) |
| Chicago Partners Investment Group LLC | 33K | $50K–$100K | SH |
| Point72 Asset Management, L.P. | 16K | $15K–$50K | SH |
| SJBENEN ADVISORY, LLC | 15K | $15K–$50K | SH |
| Ethos Financial Group, LLC | 12K | $15K–$50K | SH |
| MORGAN STANLEY | 10K | $15K–$50K | SH |
| BlackRock, Inc. | 4K | $1K–$15K | SH |
| UBS Group AG | 4K | $1K–$15K | SH |
| SBI Securities Co., Ltd. | 3K | $1K–$15K | SH |
| WELLS FARGO & COMPANY/MN | 2K | $1K–$15K | SH |
| JPMORGAN CHASE & CO | 34 | <$1K | SH |
| Larson Financial Group LLC | 22 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Aug 21, 2025
12.6%
3.0M shares
SC 13G/A · Aug 15, 2025
9.3%
1.6M shares
SC 13G · May 15, 2025
7.0%
1.2M shares
SC 13D · Sep 13, 2022
14.6%
9.9M shares
SC 13D/A · Jun 17, 2022
22.3%
14.9M shares
SC 13D · Jun 3, 2022
22.3%
14.9M shares